| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fedbd76e94c66220be69dd1ca98bf512 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b82d7db561484bc0b3bf83f29cb287ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_718818370851b90c7d775c14b9d74538
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b63fc51195f174203c752258a5f2fdd |
| publicationDate |
2016-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-2993238-A1 |
| titleOfInvention |
Prognosis of response to treatment with anti-tnf-alpha in patients with rheumatoid arthritis |
| abstract |
The present invention refers to the use of SNP rs3794271, and/or a SNP that is in total linkage disequilibrium with this SNP, as a predictive marker of the response to anti-TNF treatment in a patient with RA. The invention also refers to methods to predict the response to treatment with anti-TNF agents, as well as to decide or recommend a treatment for a patient with RA, based on the determination of rs3794271 genotype and/or a SNP that is in total linkage disequilibrium with this SNP. |
| priorityDate |
2013-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |